glp-1 consumer behavior news Is Rewriting the Food Retail Playbook How GLP-1 Medications Are Changing
Description
The mean (SD) reduction of body weight from baseline was 4.74 (1.687) kg on day 29 in 15mg dose cohort compared to 0.45 (1.460) kg in the placebo cohort
S., Morrison, D
Hormonal disruptions also affect appetite regulation, often increasing hunger and cravings
Key takeaways Research on the safety of semaglutide while breastfeeding is extremely limited
Sitagliptin, linagliptin, and alogliptin undergo minimal metabolism [66, 71, 72]
